BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29779028)

  • 1. Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.
    Iwashita Y; Ohya M; Yashiro M; Sonou T; Kawakami K; Nakashima Y; Yano T; Iwashita Y; Mima T; Negi S; Kubo K; Tomoda K; Odamaki T; Shigematsu T
    Am J Nephrol; 2018; 47(5):325-332. PubMed ID: 29779028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    McFarlane C; Ramos CI; Johnson DW; Campbell KL
    J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
    Chunchai T; Thunapong W; Yasom S; Wanchai K; Eaimworawuthikul S; Metzler G; Lungkaphin A; Pongchaidecha A; Sirilun S; Chaiyasut C; Pratchayasakul W; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    J Neuroinflammation; 2018 Jan; 15(1):11. PubMed ID: 29316965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probiotics, prebiotics or synbiotics on jawbone in obese-insulin resistant rats.
    Eaimworawuthikul S; Tunapong W; Chunchai T; Yasom S; Wanchai K; Suntornsaratoon P; Charoenphandhu N; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    Eur J Nutr; 2019 Oct; 58(7):2801-2810. PubMed ID: 30251017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Renal Clinician's Guide to the Gut Microbiota.
    Snelson M; Biruete A; McFarlane C; Campbell K
    J Ren Nutr; 2020 Sep; 30(5):384-395. PubMed ID: 31928802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Phosphorus Levels Influence Protein-Derived Uremic Toxin Production in Nephrectomized Male Rats.
    Cladis DP; Burstad KM; Biruete A; Jannasch AH; Cooper BR; Hill Gallant KM
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats.
    Yoshifuji A; Wakino S; Irie J; Tajima T; Hasegawa K; Kanda T; Tokuyama H; Hayashi K; Itoh H
    Nephrol Dial Transplant; 2016 Mar; 31(3):401-12. PubMed ID: 26487672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kidney-Gut Axis: Implications for Nutrition Care.
    Rossi M; Johnson DW; Campbell KL
    J Ren Nutr; 2015 Sep; 25(5):399-403. PubMed ID: 25812908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women.
    Ford AL; Nagulesapillai V; Piano A; Auger J; Girard SA; Christman M; Tompkins TA; Dahl WJ
    J Acad Nutr Diet; 2020 Apr; 120(4):500-516.e10. PubMed ID: 32199523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.
    Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG
    Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of probiotic, prebiotic, and synbiotic on the gut microbiota of autistic children using an in vitro gut microbiome model.
    Duque ALRF; Demarqui FM; Santoni MM; Zanelli CF; Adorno MAT; Milenkovic D; Mesa V; Sivieri K
    Food Res Int; 2021 Nov; 149():110657. PubMed ID: 34600659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.
    Musilova S; Modrackova N; Hermanova P; Hudcovic T; Svejstil R; Rada V; Tejnecky V; Bunesova V
    Benef Microbes; 2017 Apr; 8(2):281-289. PubMed ID: 28116928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
    Padagas J; Colloton M; Shalhoub V; Kostenuik P; Morony S; Munyakazi L; Guo M; Gianneschi D; Shatzen E; Geng Z; Tan HL; Dunstan C; Lacey D; Martin D
    Calcif Tissue Int; 2006 Jan; 78(1):35-44. PubMed ID: 16362459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblastic differentiation of bone marrow mesenchymal stem cells in uremic rats.
    Kato T; Mizobuchi M; Sasa K; Yamada A; Ogata H; Honda H; Sakashita A; Kamijo R
    Biochem Biophys Res Commun; 2020 Oct; 532(1):11-18. PubMed ID: 32826057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
    Mizobuchi M; Hatamura I; Ogata H; Saji F; Uda S; Shiizaki K; Sakaguchi T; Negi S; Kinugasa E; Koshikawa S; Akizawa T
    J Am Soc Nephrol; 2004 Oct; 15(10):2579-87. PubMed ID: 15466262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.